Buscar
01/07/2026
Management of the Impact of Psoriasis on Sexuality: Consensus Recommendations From the Psoriasis Working Group of the Spanish Academy of Dermatology and Venereology
Tulleuda, R, Arias-Santiago, S, Armesto, S, Carrascosa, JM, Feltes, R, Pérez-Suárez, B, de la Cueva, P, López-Ferrer, A. Management of the Impact of Psoriasis on Sexuality: Consensus Recommendations From the Psoriasis Working Group of the Spanish Academy of Dermatology and Venereology. Actas Dermo-Sifiliograficas. 2026; 117(7)DOI:10.1016/j.ad.2026.104633. PMID:41864465. IF:(Q/D).
01/07/2026
Incorporation of the family perspective in the renewal of parent information sheets
Jové-Blanco, A, Cotanda, CP, Gonzálvez, AA, Roset, MS, Capín, AM. Incorporation of the family perspective in the renewal of parent information sheets. Journal Of Healthcare Quality Research. 2026; 41(4)DOI:10.1016/j.jhqr.2026.101209. PMID:41950851. IF:(Q/D).
01/07/2026
The implementation of a streamlined TAVI patient pathway across five European countries: BENCHMARK registry
Saia, F, Lauck, S, Durand, E, Muir, DF, Spence, M, Vasa-Nicotera, M, Wood, D, Urbano-Carrillo, CA, Bouchayer, D, Iliescu, VA, Etienne, CS, Leclercq, F, Auffret, V, Asmarats, L, Di Mario, C, Veugeois, A, Maly, J, Schober, A, Nombela-Franco, L, Werner, N, Gómez-Hospital, JA, Mascherbauer, J, Musumeci, G, Meneveau, N, Meurice, T, Mahfoud, F, De Marco, F, Seidler, T, Leuschner, F, Joly, P, Collet, JP, Vogt, F, Di Lorenzo, E, Kuhn, E, Disdier, VP, McCalmont, G, Rakova, R, Wesselink, W, Kurucova, J, Hachaturyan, V, Lüske, CM, Bramlage, P, Frank, D. The implementation of a streamlined TAVI patient pathway across five European countries: BENCHMARK registry. Clinical Research in Cardiology. 2026; 115(7)DOI:10.1007/s00392-025-02638-z. PMID:40261426. IF:3.700(Q1/3D).
01/07/2026
Predictors of fibrosis, clinical events and mortality in MASLD: Data from the Global-MASLD study
Younossi, ZM, De Avila, L, Petta, S, Hagström, H, Kim, SU, Nakajima, A, Crespo, J, Castera, L, Alkhouri, N, Zheng, MH, Treeprasertsuk, S, Ananchuensook, P, Shalimar, Tsochatzis, E, Trivikrama, SK, Balakumaran, LK, Fan, JG, Roberts, SK, Alswat, K, Wong, VWS, Yilmaz, Y, Dunn, W, Francque, S, Cordie, A, Yu, ML, Ekstedt, M, Goh, GBB, Oliveira, CP, Pessoa, MG, Chan, WK, Fernandez, MIC, Duseja, A, Arab, JP, Papatheodoridis, G, Sebastiani, G, Villela-Nogueira, C, D'Ambrosio, R, Lampertico, P, Alnaamani, K, Holleboom, AG, Valsan, A, Venu, A, El-Kassas, M, Pennisi, G, Shang, Y, Liu, WY, Lee, HW, Kobayashi, T, Kakizaki, S, Caussy, C, Pearlman, B, Iruzubieta, P, Nadeem, R, Cinque, F, Neonaki, A, Zoncapé, M, Yang, RX, Song, SJ, Dunn, N, Gadi, Z, Yeh, ML, The, KKJ, Mahadeva, S, Fabian, LG, Almohsen, A, Leite, N, Pugliese, N, Vessby, J, Xie, CC, Choudhary, NS, Friend, E, Poca, M, Kawaguchi, T, Russo, FP, Gadano, A, Diaz, LA, Singal, AK, Segrestin, B, Gunn, N, Mauricio, D, Arrese, M, Fracanzani, A, Lam, B, Racila, A, Alqahtani, SA, Stepanova, M. Predictors of fibrosis, clinical events and mortality in MASLD: Data from the Global-MASLD study. HEPATOLOGY. 2026; 84(1)DOI:10.1097/HEP.0000000000001617. PMID:41231627. IF:15.800(Q1/1D).
01/07/2026
Global performance of non-invasive tests in MASLD: Insights from the G-MASLD study
Younossi, ZM, de Avila, L, Petta, S, Hagström, H, Kim, SU, Nakajima, A, Crespo, J, Castera, L, Alkhouri, N, Zheng, MH, Treeprasertsuk, S, Ananchuensook, P, Shalimar, Tsochatzis, E, Trivikrama, SK, Balakumaran, LK, Fan, JG, Roberts, SK, Alswat, K, Wong, VWS, Yilmaz, Y, Dunn, W, Francque, S, Cordie, A, Yu, ML, Ekstedt, M, Goh, GBB, Oliveira, CP, Pessoa, MG, Chan, WK, Fernandez, MIC, Duseja, A, Arab, JP, Papatheodoridis, G, Sebastiani, G, Villela-Nogueira, C, D'Ambrosio, R, Lampertico, P, Alnaamani, K, Holleboom, AG, Valsan, A, Venu, A, El-Kassas, M, Pennisi, G, Shang, Y, Liu, WY, Lee, HW, Kobayashi, T, Kakizaki, S, Caussy, C, Pearlman, B, Iruzubieta, P, Nadeem, R, Cinque, F, Neonaki, A, Zoncapé, M, Yang, RX, Song, SJ, Dunn, N, Gadi, Z, Yeh, ML, Kim-Jun, K, Mahadeva, S, Fabian, LG, Almohsen, A, Leite, N, Pugliese, N, Vessby, J, Xie, CC, Choudhary, NS, Friend, E, Poca, M, Kawaguchi, T, Russo, FP, Gadano, A, Diaz, LA, Singal, AK, Segrestin, B, Gunn, N, Mauricio, D, Arrese, M, Fracanzani, A, Lombardi, R, Lam, B, Racila, A, Alqahtani, SA, Stepanova, M. Global performance of non-invasive tests in MASLD: Insights from the G-MASLD study. HEPATOLOGY. 2026; 84(1)DOI:10.1097/HEP.0000000000001564. PMID:41100867. IF:15.800(Q1/1D).
01/07/2026
Clinical utility of the DENOVA score for predicting infective endocarditis in Enterococcus faecalis bacteraemia: external validation with decision curve analysis
Varisco, B, Piovani, D, Del Turco, ER, Bussini, L, Paul, M, Sabik, EF, Castagna, A, Ripa, M, Gomes, MZR, Di Bella, S, Zerbato, V, Lopez, AB, Franceschini, E, Bandera, A, Oliva, A, Gavaruzzi, F, Muñoz, P, Mularoni, A, Seminari, E, Morelli, P, Pocaterra, D, Tascini, C, Papadimitriou-Olivgeris, M, Coppola, N, Cristini, F, Russo, A, Bassetti, M, Travi, G, Lopez-Contreras, J, Viale, P, Cento, V, Diella, L, Bavaro, DF, Gaibani, P, Giannella, M, Bartoletti, M. Clinical utility of the DENOVA score for predicting infective endocarditis in Enterococcus faecalis bacteraemia: external validation with decision curve analysis. CLINICAL MICROBIOLOGY AND INFECTION. 2026; 32(7)DOI:10.1016/j.cmi.2026.02.019. PMID:41748017. IF:8.500(Q1/1D).
01/07/2026
Unraveling the spatial landscape of dystrophinopathies: a transcriptomic approach to Becker and Duchenne muscular dystrophies
Heezen, LG, Mao, QR, Nicolau, S, Rausell, CN, van der Weerd, J, Kueckelhaus, J, Nath, RG, Manera, JD, Kan, HE, Niks, EH, van Putten, M, Aartsma-Rus, A, Flanigan, KM, Mahfouz, A, Spitali, P. Unraveling the spatial landscape of dystrophinopathies: a transcriptomic approach to Becker and Duchenne muscular dystrophies. JOURNAL OF PATHOLOGY. 2026; 269(3)DOI:10.1002/path.70067. PMID:42067897. IF:5.200(Q1/1D).
01/07/2026
Visual mapping of muscle MRI fatty replacement patterns in genetic myopathies using dimensionality reduction
Pizarro-Galleguillos, B, Verdú-Diaz, J, Gómez-Andrés, D, Tobar, F, Montalba, C, Andia, M, Diaz-Manera, J, Jara, JD, Bevilacqua, JA. Visual mapping of muscle MRI fatty replacement patterns in genetic myopathies using dimensionality reduction. NEUROMUSCULAR DISORDERS. 2026; 64DOI:10.1016/j.nmd.2026.106464. PMID:42263369. IF:2.800(Q2/5D).
01/07/2026
Prognostic Determinants of Presentation and Outcome in Anti-IgLON5 Disease
Sabater, L, Guasp, M, García, RR, Rondán, LN, Querol, L, Martín-Aguilar, L, Llarch, P, Balasa, M, Lladó, A, Painous, C, Compta, Y, Serafim, AB, Montini, A, Iranzo, A, Cano, JS, Dalmau, JO, Graus, F, Gaig, C. Prognostic Determinants of Presentation and Outcome in Anti-IgLON5 Disease. Neurology-Neuroimmunology & Neuroinflammation. 2026; 13(4)DOI:10.1212/NXI.0000000000200600. PMID:42241645. IF:7.500(Q1/1D).
01/07/2026
Sensory neuronopathy secondary to gene therapy with AT845 for Pompe disease
Pena-Guzman, L, Bolano-Díaz, C, Lleixà, C, Querol, L, Trainor, C, Suetterlin, K, Straub, V, Díaz-Manera, J. Sensory neuronopathy secondary to gene therapy with AT845 for Pompe disease. NEUROMUSCULAR DISORDERS. 2026; 64DOI:10.1016/j.nmd.2026.106441. PMID:42142433. IF:2.800(Q2/5D).
01/07/2026
Rates and risk factors for major adverse cardiovascular and cerebrovascular events after stroke due to intracerebral hemorrhage: Systematic review and study-level meta-analysis
Putri, VP, Samarasekera, N, Moullaali, TJ, Jampana, S, Aked, J, Åsberg, S, Schulman, S, Tsivgoulis, G, Pikilidou, M, Tsai, HH, Tsai, LK, Myint, PK, Pana, TA, Cordonnier, C, Casolla, B, Gaist, D, Pezzini, A, Camps-Renom, P, Klijn, CJM, Romoli, M, Tveiten, A, Liu, M, Xu, MM, Wu, B, Werring, D, Nash, PS, Banerjee, G, Li, LX, Salman, RAS. Rates and risk factors for major adverse cardiovascular and cerebrovascular events after stroke due to intracerebral hemorrhage: Systematic review and study-level meta-analysis. International Journal of Stroke. 2026; 21(6)DOI:10.1177/17474930261416692. PMID:41605872. IF:8.700(Q1/1D).
01/07/2026
Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody-drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
Majem, M, Mata, KM, Ibarguren, AM, Poves, MZ, Requena, C, Aparisi, FDA, Carrera, C, Cordellat, AB, Freites-Martinez, A, Sanmartin, O. Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody-drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology. Clinical & Translational Oncology. 2026; 28(7)DOI:10.1007/s12094-025-04209-0. PMID:41604110. IF:2.500(Q3/6D).
01/07/2026
Clinical outcomes of deferred cytoreductive nephrectomy after initial systemic therapy in metastatic renal cell carcinoma: A multicenter retrospective study
Rioja, P, Passarella, C, Angel, M, Valderrama, W, Ainaud, FB, Anguera, G, Gómez, V, Ruiz-Granados, A, Plata, D, Zapata, MI, Orta-Ruiz, A, Quiroga, MNG, Bourlon, MT, Grande, E, Kopp, RM, Molina-Cerrillo, J, Maroto, P, Sade, JP, Castellano, D. Clinical outcomes of deferred cytoreductive nephrectomy after initial systemic therapy in metastatic renal cell carcinoma: A multicenter retrospective study. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 2026; 44(7)DOI:10.1016/j.urolonc.2026.04.008. PMID:42139851. IF:2.300(Q2/5D).
01/07/2026
Efficacy and safety of subcutaneous and intravenous administration of atezolizumab in patients with non-small cell lung cancer, including early-stage, locally advanced or metastatic disease: Updated results of the IMscin001 and IMscin002 randomized studies
Burotto, M, Zvirbule, Z, Alvarez, R, Chewaskulyong, B, Felip, E, Majem, M, Korbenfeld, E, Kolb-Sielecki, J, Isla, D, Barata, T, Bustillos, A, Herraez-Baranda, LA, Tosti, N, Young, F, Zanghi, J, Cappuzzo, F. Efficacy and safety of subcutaneous and intravenous administration of atezolizumab in patients with non-small cell lung cancer, including early-stage, locally advanced or metastatic disease: Updated results of the IMscin001 and IMscin002 randomized studies. LUNG CANCER. 2026; 217DOI:10.1016/j.lungcan.2026.109452. PMID:42214243. IF:4.400(Q1/2D).
01/07/2026
Are we managing desmoid tumors correctly in Spain? Results of the first national survey
Olivares-Ripoll, V, Lominchar, PL, Muñoz, P, Ballester, C, Diaz, D, Marrero, P, Cambeiro, L, Lopez, I, Vásquez, H, Casares, CM, Lopez, JAG, Asencio, JM. Are we managing desmoid tumors correctly in Spain? Results of the first national survey. CIRUGIA ESPANOLA. 2026; 104(7)DOI:10.1016/j.ciresp.2026.800333. PMID:. IF:1.300(Q3/7D).
01/07/2026
A commemoration and appreciation of Professor Ben Mijnheer
Thwaites, DI, Jornet, N, Georg, D, Muren, L, Thorwarth, D, van Elmpt, W, Aznar, M, Knausl, B, Vedelago, J. A commemoration and appreciation of Professor Ben Mijnheer. RADIOTHERAPY AND ONCOLOGY. 2026; 220DOI:10.1016/j.radonc.2026.111586. PMID:42127568. IF:5.300(Q1/2D).
01/07/2026
Spanish Clinical Management Guideline for Hidradenitis Suppurativa. Part I: Pathogenesis, Diagnosis, and Disease Staging
Martorell, A, Roldán, FA, García-Martínez, FJ, Leyva, AM, Ramírez, JCP, Vilarrasa, E. Spanish Clinical Management Guideline for Hidradenitis Suppurativa. Part I: Pathogenesis, Diagnosis, and Disease Staging. Actas Dermo-Sifiliograficas. 2026; 117(7)DOI:10.1016/j.ad.2026.104639. PMID:41865977. IF:(Q/D).
01/07/2026
The State of the Art in Chronic Prurigo Nodularis
Serra-Baldrich, E, Flórez, A, Manresa, MJ, de Frutos, FJO, Pereyra-Rodriguez, JJ, Pérez, B, Figueras, I. The State of the Art in Chronic Prurigo Nodularis. Dermatology and Therapy. 2026; 16(7)DOI:10.1007/s13555-026-01804-z. PMID:42247108. IF:4.200(Q1/1D).
01/07/2026
Digital Uromonitor® outperforms quantitative polymerase chain reaction Uromonitor and cytology for non-muscle-invasive bladder cancer surveillance: results from the 'External Validation of Uromonitor as a Biomarker for Optimization of NMIBC Management by the Club Urológico Español de Tratamiento Oncológico Group' (EVALUATION-CUETO) study
Rubio-Briones, J, Ramos, FG, Sánchez, AM, Abadía, IB, Rodríguez, RM, Alcaraz, A, Legaz, MM, Lozano, F, Martín, MA, Cardo, AL, Rodríguez, VG, Velasco, JC, Liesa, MS, Pareja, CF, Ortiz, RE, de Torres, IG, Zalabardo, DS, Guijarro, A, Mengual, L, Borque-Fernando, A, Escaño, LME, Redorta, JP, Witjes, F, Piñeiro, LM. Digital Uromonitor® outperforms quantitative polymerase chain reaction Uromonitor and cytology for non-muscle-invasive bladder cancer surveillance: results from the 'External Validation of Uromonitor as a Biomarker for Optimization of NMIBC Management by the Club Urológico Español de Tratamiento Oncológico Group' (EVALUATION-CUETO) study. BJU INTERNATIONAL. 2026; 138(1)DOI:10.1111/bju.70230. PMID:41941336. IF:4.400(Q1/2D).
01/07/2026
Long-term outcomes of COVID-19 in primary care: 5-Year follow-up of hospitalized and non-hospitalized patients in a population-based cohort study
Lafont, PM, Pelaez, IM, Cuixart, CB. Long-term outcomes of COVID-19 in primary care: 5-Year follow-up of hospitalized and non-hospitalized patients in a population-based cohort study. Medicina De Familia-Semergen. 2026; 52(5)DOI:10.1016/j.semerg.2026.102781. PMID:42235195. IF:(Q/D).